Toll-like receptor 4 signaling is associated with upregulated NADPH oxidase expression in peripheral T cells of children with autism

Brain, Behavior, and Immunity

Volumn 61, Issue , 2017, Pages 146-154

  Nadeem, Ahmed ^a   Ahmad, Sheikh F ^a   Bakheet, Saleh A ^a   Al Harbi, Naif O ^a   AL Ayadhi, Laila Y ^b   Attia, Sabry M ^a   Zoheir, Khairy M A ^a,c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Autism; NADPH oxidase; Reactive oxygen species; T cell; Toll like receptor 4

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

ARTICLE; AUTISM; CD4+ T LYMPHOCYTE; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; NERVOUS SYSTEM INFLAMMATION; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SCHOOL CHILD; SIGNAL TRANSDUCTION; T LYMPHOCYTE; GENETICS; METABOLISM; PHYSIOLOGY; UPREGULATION;

AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NADPH OXIDASES; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 85008474570     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.12.024     Document Type: Article

References (47)

1. Ahmad, S.F., Zoheir, K.M., Ansari, M.A., Nadeem, A., Bakheet, S.A., Al-Ayadhi, L.Y., Alzahrani, M.Z., Al-Shabanah, O.A., Al-Harbi, M.M., Attia, S.M., Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism. Mol. Neurobiol., 2016, 10.1007/s12035-016-9977-0 (Epub ahead of print).
2. AL-Ayadhi, L.Y., Mostafa, G.A., Serum antinucleosome-specific antibody as a marker of autoimmunity in children with autism. J. Neuroinflamm., 3(11), 2014, 69.
3. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. fifth ed., 2015, American Psychiatric Association, Arlington, VA (DSM-5).
4. Amico, D., Spadoni, T., Rovinelli, M., Serafini, M., D'Amico, G., Campelli, N., Svegliati Baroni, S., Gabrielli, A., Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2. Arthritis Res. Ther., 17, 2015, 68.
5. Anrather, J., Racchumi, G., Iadecola, C., NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. J. Biol. Chem. 281 (2006), 5657–5667.
6. Ashwood, P., Wills, S., Van de Water, J., The immune response in autism: a new frontier for autism research. J. Leuk. Biol. 80 (2006), 1–15.
7. Bae, Y.S., Lee, J.H., Choi, S.H., Kim, S., Almazan, F., Witztum, J.L., Miller, Y.I., Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ. Res. 104 (2009), 210–218.
8. Bedard, K., Krause, K.H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87 (2007), 245–313.
9. Bergeron, J.D., Deslauriers, J., Grignon, S., Fortier, L.C., Lepage, M., Stroh, T., Poyart, C., Sébire, G., White matter injury and autistic-like behavior predominantly affecting male rat offspring exposed to group B streptococcal maternal inflammation. Dev. Neurosci. 35 (2013), 504–515.
10. Bradstreet, J.J., Smith, S., Baral, M., Rossignol, D.A., Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder. Altern. Med. Rev. 15 (2010), 15–32.
11. Cortelazzo, A., De Felice, C., Guerranti, R., Signorini, C., Leoncini, S., Zollo, G., Leoncini, R., Timperio, A.M., Zolla, L., Ciccoli, L., Hayek, J., Expression and oxidative modifications of plasma proteins in autism spectrum disorders: interplay between inflammatory response and lipid peroxidation. Proteomics Clin. Appl. 10 (2016), 1103–1112.
12. de Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., Carteni, M., De Rosa, M., Francavilla, R., Riegler, G., Militerni, R., Bravaccio, C., Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J. Pediatr. Gastroenterol. Nutr. 51 (2010), 418–424.
13. Enstrom, A.M., Onore, C.E., Van de Water, J.A., Ashwood, P., Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav. Immun. 24 (2010), 64–71.
14. García Bueno, B., Caso, J.R., Madrigal, J.L., Leza, J.C., Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases. Neurosci. Biobehav. Rev. 64 (2016), 134–147.
15. Ghosh, S., Hayden, M.S., New regulators of NF-kB in Inflammation. Nat. Rev. Immunol. 8 (2008), 837–848.
16. Han, Y., Xi, Q.Q., Dai, W., Yang, S.H., Gao, L., Su, Y.Y., Zhang, X., Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders. Int. J. Dev. Neurosci. 46 (2015), 27–32.
17. Hsiao, E.Y., Gastrointestinal issues in autism spectrum disorder. Harv. Rev. Psychiatry 22 (2014), 104–111.
18. Hsiao, E.Y., McBride, S.W., Chow, J., Mazmanian, S.K., Patterson PH. Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 12776–12781.
19. Jackson, S.H., Devadas, S., Kwon, J., Pinto, L.A., Williams, M.S., T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat. Immunol. 5 (2004), 818–827.
20. James, S.J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D.W., Neubrander, J.A., Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80 (2004), 1611–1617.
21. Kirsten, T.B., Lippi, L.L., Bevilacqua, E., Bernardi, M.M., LPS exposure increases maternal corticosterone levels, causes placental injury and increases IL-1β levels in adult rat offspring: relevance to autism. PLoS One, 8, 2013, e82244.
22. Le Belle, J.E., Sperry, J., Ngo, A., Ghochani, Y., Laks, D.R., López-Aranda, M., Silva, A.J., Kornblum, H.I., Maternal inflammation contributes to brain overgrowth and autism-associated behaviors through altered redox signaling in stem and progenitor cells. Stem Cell Rep. 3 (2014), 725–734.
23. Levy, S.E., Mandell, D.S., Schultz, R.T., Autism. Lancet 374 (2009), 1627–1638.
24. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001), 402–408.
25. Lucas, K., Maes, M., Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol. Neurobiol. 48 (2013), 190–204.
26. Masood, A., Nadeem, A., Mustafa, S.J., O'Donnell, J.M., Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J. Pharmacol. Exp. Ther. 326 (2008), 369–379.
27. Mittal, M., Siddiqui, M.R., Tran, K., Reddy, S.P., Malik, A.B., Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 20 (2014), 1126–1167.
28. Nadeem, A., Siddiqui, N., Alharbi, N.O., Alharbi, M.M., Airway and systemic oxidant-antioxidant dysregulation in asthma: a possible scenario of oxidants spill over from lung into blood. Pulm. Pharmacol. Ther. 29 (2014), 31–40.
29. Nadeem, A., Al-Harbi, N.O., Al-Harbi, M.M., El-Sherbeeny, A.M., Ahmad, S.F., Siddiqui, N., Ansari, M.A., Zoheir, K.M., Attia, S.M., Al-Hosaini, K.A., Al-Sharary, S.D., Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation. Pharmacol. Res. 99 (2015), 248–257.
30. Nadeem, A., Alharbi, N.O., Vliagoftis, H., Tyagi, M., Ahmad, S.F., Sayed-Ahmed, M.M., Protease activated receptor-2 mediated dual oxidase-2 upregulation is involved in enhanced airway reactivity and inflammation in a mouse model of allergic asthma. Immunology 145 (2015), 391–403.
31. Nadeem, A., Siddiqui, N., Al-Harbi, N.O., Al-Harbi, M.M., Ahmad, S.F., TLR-7 agonist attenuates airway reactivity and inflammation through Nrf2-mediated antioxidant protection in a murine model of allergic asthma. Int. J. Biochem. Cell Biol. 73 (2016), 53–62.
32. Naik, U.S., Gangadharan, C., Abbagani, K., Nagalla, B., Dasari, N., Manna, S.K., A study of nuclear transcription factor-kappa B in childhood autism. PLoS One, 6, 2011, e19488.
33. Napoli, E., Wong, S., Hertz-Picciotto, I., Giulivi, C., Deficits in bioenergetics and impaired immune response in granulocytes from children with autism. Pediatrics 133 (2014), e1405–e1410.
34. Onore, C., Careaga, M., Ashwood, P., The role of immune dysfunction in the pathophysiology of autism. Brain Behav. Immun. 26 (2012), 383–392.
35. Padgett, L.E., Tse, H.M., NADPH oxidase-derived superoxide provides a third signal for CD4 T cell effector responses. J. Immunol. 197 (2016), 1733–1742.
36. Patterson, P.H., Maternal infection and immune involvement in autism. Trends Mol. Med. 17 (2011), 389–394.
37. Reynolds, J.M., Martinez, G.J., Chung, Y., Dong, C., Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 13064–13069.
38. Rose, S., Melnyk, S., Pavliv, O., Bai, S., Nick, T.G., Frye, R.E., James, S.J., Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl. Psychiatry, 2, 2012, e134.
39. Sajdel-Sulkowska, M.E., Windom, H., Audhya, T., McGinnis, W., Oxidative stress in autism: elevated cerebellar 3-nitrotyrosine levels. Am. J. Biochem. Biotechnol. 4 (2008), 73–84.
40. Schiavone, S., Trabace, L., Pharmacological targeting of redox regulation systems as new therapeutic approach for psychiatric disorders: a literature overview. Pharmacol. Res. 107 (2016), 195–204.
41. Schopler, E., Reichler, R.J., Renner, B.R., 1986. The Childhood Autism Rating Scale (CARS): For Diagnostic Screening and Classification of Autism. Irvington, New York.
42. Theoharides, T.C., Tsilioni, I., Patel, A.B., Doyle, R., Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders. Transl. Psychiatry, 6, 2016, e844.
43. Vallabhapurapu, S., Karin, M., Regulation and function of NF-KB transcription in the immune system. Annu. Rev. Immunol. 27 (2009), 693–733.
44. Wang, H., Joseph, J.A., Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 27 (1999), 612–616.
45. Wang, L., Jia, J., Zhang, J., Li, K., Serum levels of SOD and risk of autism spectrum disorder: a case-control study. Int. J. Dev. Neurosci. 51 (2016), 12–16.
46. Young, A.M., Campbell, E., Lynch, S., Suckling, J., Powis, S.J., Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation. Front. Psychiatry, 13(2), 2011, 27.
47. Zanin-Zhorov, A., Tal-Lapidot, G., Cahalon, L., Cohen-Sfady, M., Pevsner-Fischer, M., Lider, O., Cohen, I.R., Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J. Immunol. 179 (2007), 41–44.